Recent Events & Catalysts
BioMarin Pharmaceutical (BMRN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Score Changeyesterday
BMRN committee score fell 1.3 points
BMRN's Committee score moved from 58.42 to 57.12 (-1.30, 1 day(s) apart).
Score Change2d ago
BMRN committee score rose 1.4 points
BMRN's Committee score moved from 57.05 to 58.42 (+1.37, 1 day(s) apart).
Score Change4d ago
BMRN committee score fell 1.7 points
BMRN's Committee score moved from 58.71 to 57.05 (-1.66, 1 day(s) apart).
Conviction Change8d ago
BMRN conviction changed
BMRN's Committee conviction moved from contested to moderate (1 day(s) apart).
Agreement Shift8d ago
BMRN analyst agreement shifted
BMRN's Committee agreement moved from 57.10% to 60.00% (+2.90pp, 1 day(s) apart).
Score Change8d ago
BMRN committee score fell 0.1 points
BMRN's Committee score moved from 57.16 to 57.05 (-0.11, 1 day(s) apart).
News
BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET
Yahoo · 2d ago
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
Yahoo · 4d ago
BioMarin and n-Lorem partner on early research for ReNU syndrome therapy
Yahoo · 4d ago
Analysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out for
Yahoo · 5d ago
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
Yahoo · 5d ago
BioMarin Pharmaceutical (NASDAQ:BMRN): A Value Stock with Strong Fundamentals
ChartMill · 5d ago
BioMarin Pharmaceutical Enters Global Exclusive License Agreement And Collaboration With n-Lorem Foundation To Develop A First-In-Disease, Antisense Oligonucleotide Medicine For People Living With ReN
Benzinga · 5d ago
BioMarin Pharmaceutical (NASDAQ:BMRN) Presents a High-Quality Breakout Setup with Strong Technical Ratings
ChartMill · 7d ago
SEC Filings (90 days)
Other events, Financial statements and exhibits
Filed 2026-07-13 · 19d ago
Departure/appointment of directors or officers, Submission of matters to a vote of security holders
Filed 2026-06-04 · 58d ago
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-05-04 · 89d ago · Material
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.